Corium

Corium is a commercial-stage biopharmaceutical company specializing in the development and commercialization of therapies for central nervous system (CNS) disorders. The company collaborates with major pharmaceutical and consumer product companies to bring products from concept through development to manufacturing and final commercialization. Corium's proprietary transdermal technologies enable the delivery of both small and large molecule therapeutics, offering significant clinical and commercial advantages. The company primarily serves clinicians, patients, their families, and caregivers by providing important treatment options for disorders such as ADHD and Alzheimer's disease. Corium operates in the biopharmaceutical market and generates revenue through the sale and licensing of its innovative CNS therapies.

Keywords: CNS therapies, biopharmaceutical, ADHD, Alzheimer's, transdermal technologies, commercialization, healthcare, clinicians, patients, caregivers.